|Source||Humanized (from mouse)|
|14px (what is this?)|
Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Dalotuzumab was developed by Merck & Co., Inc.
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Dalotuzumab" (PDF). American Medical Association.
Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.